TRVI logo
Trevi Therapeutics, Inc.(TRVI)
Last print unknown agoAbout this dataData status
$11.90▲0.02 (0.17%)Stale · unknown old

TRVI Operating Cash Flow (Statement)

-$52.63MTTM · USD

Period ending:

TRVI FY Cash from OperationsUSD
TRVI FY Cash from Operations2016-12-31: -$11.19M2017-12-31: -$7.98M2018-12-31: -$18.29M2019-12-31: -$23.09M2020-12-31: -$29.00M2021-12-31: -$28.95M2022-12-31: -$28.18M2023-12-31: -$31.71M2024-12-31: -$38.26M2025-12-31: -$42.09M$0.00-$42.09M
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TRVI operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Trevi Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-42,089,000
-38,256,000
-31,710,000
-28,175,000
-28,946,000
-29,000,000
-23,093,000
-18,291,000
-7,975,000
-11,192,000

Compare operating cash flow (statement)

All TRVI financial metrics · TRVI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.